MGP
Matrix Gla protein
Also known as: MGP_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P08493
- Gene
- MGP
- Ensembl
- ENSG00000111341
- Chromosome
- 12
- Canonical length
- 103 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene encodes a member of the osteocalcin/matrix Gla family of proteins. The encoded vitamin K-dependent protein is secreted by chondrocytes and vascular smooth muscle cells, and functions as a physiological inhibitor of ectopic tissue calcification. Carboxylation status of the encoded protein is associated with calcification of the vasculature in human patients with cardiovascular disease and calcification of the synovial membranes in osteoarthritis patients. Mutations in this gene cause Keutel syndrome in human patients, which is characterized by abnormal cartilage calcification, peripheral pulmonary stenosis and facial hypoplasia. [provided by RefSeq, Sep 2016]
Canonical amino-acid sequenceUniProt
103 residues, UniProt reviewed canonical sequence.
>P08493|MGP
1 MKSLILLAIL AALAVVTLCY ESHESMESYE LNPFINRRNA NTFISPQQRW RAKVQERIRE
61 RSKPVHELNR EACDDYRLCE RYAMVYGYNA AYNRYFRKRR GTKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MGP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.46
- Highest tissue expression
- 15,728 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 15,728 nTPM
- breast: 3,496 nTPM
- heart muscle: 2,767 nTPM
- fallopian tube: 2,403 nTPM
- salivary gland: 1,985 nTPM
- endometrium: 1,853 nTPM
Single-cell type
- breast secretory cells: 17,168 nCPM
- breast hormone-responsive cells: 10,283 nCPM
- fibroblasts: 4,591 nCPM
- salivary acinar cells: 4,296 nCPM
- breast myoepithelial cells: 2,793 nCPM
- vascular smooth muscle cells: 2,108 nCPM
Immune cell
- plasmacytoid DC: 1.6 nTPM
- gdT-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- choroid plexus: 330 nTPM
- cerebral cortex: 56 nTPM
- basal ganglia: 48 nTPM
- thalamus: 39 nTPM
- medulla oblongata: 33 nTPM
- spinal cord: 28 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MGP.
Disease | AllUniProt
Conditions MGP is implicated in, by any mechanism.
- Keutel syndrome (KTLS) MIM:245150
Disease | GeneticClinVar
5 pathogenic / likely-pathogenic of 134 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Keutel syndrome
Disease | ImmuneIEDB
Conditions an epitope on MGP was assayed in.
- skin melanoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.66
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.12
- DepMap mean gene effect
- 0.11
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MGP as an antibody target. Whether an autoantibody or antibody against MGP could matter depends on whether native MGP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MGP is annotated as secreted, so native MGP circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label MGP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...